Why the study?
Common respiratory viral infections frequently complicate hematopoietic stem cell transplantation, but their incidence needed to be determined.
Population
Patients who received an allogeneic or autologous HSCT at the Royal Adelaide Hospital between 2009 and 2017
Comparison
Allogeneic vs autologous HSCT recipients
Design
Retrospective, single-center, observational cohort study
Follow-up
Median 8.9 years for auto-HSCT and 4.5 years for allo-HSCT recipients
Authors
Loading...
CRVI burden data warrant vigilance in HSCT units; leaves open prospective trials of prevention strategies.
Common respiratory viral infections are a significant cause of late morbidity and potential mortality in HSCT recipients, highlighting the need for strict infection control and vaccination.
Marinelli et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: